Header cover image

Japanese (NIKKEI) Biotech Industry Analysis

UpdatedMar 22, 2025
DataAggregated Company Financials
Companies34
  • 7D1.8%
  • 3M-1.1%
  • 1Y18.7%
  • YTDn/a

Over the last 7 days, the Biotech industry has risen 1.8%, driven by gains from SanBio of 18%. In the last 12 months, the industry was up 19%. Looking forward, earnings are forecast to grow by 21% annually.

Industry Valuation and Performance

Has the Japanese Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 22 Mar 2025JP¥1.0tJP¥207.8b-JP¥39,285,917,000.0015.9x-26.7x5x
Mon, 17 Feb 2025JP¥1.1tJP¥207.4b-JP¥38,725,311,000.0016.1x-27.6x5.2x
Wed, 15 Jan 2025JP¥1.0tJP¥207.3b-JP¥13,531,081,000.0021.2x-75.8x4.9x
Fri, 13 Dec 2024JP¥1.0tJP¥207.2b-JP¥12,080,899,000.0021.7x-86.5x5x
Sun, 10 Nov 2024JP¥1.1tJP¥215.8b-JP¥6,555,528,000.0022.3x-164.2x5x
Tue, 08 Oct 2024JP¥1.1tJP¥214.3b-JP¥2,078,229,000.0021.9x-550.3x5.3x
Thu, 05 Sep 2024JP¥1.1tJP¥210.1b-JP¥469,229,000.0015.6x-2253.9x5x
Sat, 03 Aug 2024JP¥998.4bJP¥187.5b-JP¥16,095,901,000.0054.4x-62x5.3x
Mon, 01 Jul 2024JP¥994.5bJP¥187.7b-JP¥15,773,284,000.0089.8x-63x5.3x
Wed, 29 May 2024JP¥786.6bJP¥195.7b-JP¥14,072,545,000.0094.6x-55.9x4x
Fri, 26 Apr 2024JP¥745.6bJP¥198.9b-JP¥14,917,877,000.0041.6x-50x3.7x
Sun, 24 Mar 2024JP¥773.8bJP¥194.2b-JP¥15,457,633,000.0060.7x-50.1x4x
Tue, 20 Feb 2024JP¥834.1bJP¥196.2b-JP¥18,777,765,000.0066.2x-44.4x4.3x
Thu, 18 Jan 2024JP¥782.4bJP¥222.3b-JP¥12,605,455,000.0017.2x-62.1x3.5x
Sat, 16 Dec 2023JP¥751.0bJP¥221.9b-JP¥12,379,781,000.0016.9x-60.7x3.4x
Mon, 13 Nov 2023JP¥735.1bJP¥221.2b-JP¥8,793,085,000.0017.1x-83.6x3.3x
Wed, 11 Oct 2023JP¥824.5bJP¥223.0b-JP¥14,518,735,000.0024.3x-56.8x3.7x
Fri, 08 Sep 2023JP¥894.4bJP¥225.4b-JP¥19,581,085,000.0045.4x-45.7x4x
Sun, 06 Aug 2023JP¥894.4bJP¥223.7b-JP¥20,858,086,000.0049.8x-42.9x4x
Tue, 04 Jul 2023JP¥983.7bJP¥223.0b-JP¥19,224,671,000.0059.8x-51.2x4.4x
Thu, 01 Jun 2023JP¥923.8bJP¥218.4b-JP¥25,404,669,000.0034.3x-36.4x4.2x
Sat, 29 Apr 2023JP¥902.6bJP¥218.1b-JP¥20,115,522,000.0020.9x-44.9x4.1x
Mon, 27 Mar 2023JP¥931.0bJP¥218.3b-JP¥21,583,164,000.0020.6x-43.1x4.3x
Wed, 22 Feb 2023JP¥955.9bJP¥216.2b-JP¥18,991,580,000.0021.1x-50.3x4.4x
Fri, 20 Jan 2023JP¥909.9bJP¥186.8b-JP¥24,722,604,000.0039.9x-36.8x4.9x
Sun, 18 Dec 2022JP¥906.0bJP¥186.8b-JP¥24,723,808,000.0043.6x-36.6x4.8x
Tue, 15 Nov 2022JP¥926.6bJP¥180.2b-JP¥24,569,725,000.0050.2x-37.7x5.1x
Thu, 13 Oct 2022JP¥855.3bJP¥176.5b-JP¥24,974,270,000.0041.8x-34.2x4.8x
Sat, 10 Sep 2022JP¥937.9bJP¥177.6b-JP¥23,522,270,000.0051x-39.9x5.3x
Mon, 08 Aug 2022JP¥971.4bJP¥170.4b-JP¥18,266,562,000.0020.7x-53.2x5.7x
Wed, 06 Jul 2022JP¥863.0bJP¥171.3b-JP¥16,112,943,000.0020.1x-53.6x5x
Fri, 03 Jun 2022JP¥892.0bJP¥169.3b-JP¥13,461,721,000.0011.2x-66.3x5.3x
Sun, 01 May 2022JP¥1.0tJP¥163.9b-JP¥13,144,295,000.0013.9x-76.6x6.1x
Tue, 29 Mar 2022JP¥1.1tJP¥164.2b-JP¥13,044,654,000.0015.2x-81.5x6.5x
Price to Earnings Ratio

-81.5x


Total Market Cap: JP¥1.1tTotal Earnings: -JP¥13,044,654,000.00Total Revenue: JP¥164.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Biotech Industry Price to Earnings3Y Average -125.9x202320242025
Current Industry PE
  • Investors are relatively neutral on the Japanese Biotechnology industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 4.6x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 8.1% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Japanese Biotech compare with similar industries?

JP Market2.92%
Healthcare1.81%
Biotech1.75%
Biotech1.75%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4592 SanBioJP¥1.36k18.0%
+JP¥14.7b
134.1%PB54.7x
4894 CuoripsJP¥8.43k20.1%
+JP¥11.3b
149.4%PS2936.7x
219A HeartseedJP¥2.34k16.7%
+JP¥7.5b
n/aPS60x
4882 Perseus ProteomicsJP¥1.03k49.9%
+JP¥5.1b
184.8%PS136.8x
4974 Takara BioJP¥856.001.8%
+JP¥1.8b
-15.2%PS2.4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

4592

JP¥1,360.00

SanBio

7D

18.0%

1Y

134.1%

4978

JP¥155.00

ReproCELL

7D

-4.9%

1Y

-2.5%

4974

JP¥856.00

Takara Bio

7D

1.8%

1Y

-15.2%

4882

JP¥1,034.00

Perseus Proteomics

7D

49.9%

1Y

184.8%

4891

JP¥179.00

TMS

7D

-13.1%

1Y

-39.3%

4571

JP¥153.00

NANO MRNALtd

7D

-3.8%

1Y

-14.0%

4599

JP¥338.00

StemRIM

7D

-1.5%

1Y

-33.5%

4591

JP¥112.00

Ribomic

7D

-5.9%

1Y

24.4%

4564

JP¥29.00

OncoTherapy Science

7D

11.5%

1Y

38.1%

4588

JP¥770.00

Oncolys BioPharma

7D

7.1%

1Y

24.0%

219A

JP¥2,344.00

Heartseed

7D

16.7%

1Y

n/a

190A

JP¥270.00

Chordia Therapeutics

7D

5.5%

1Y

n/a

4894

JP¥8,430.00

Cuorips

7D

20.1%

1Y

149.4%